BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7248475)

  • 1. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).
    Gulaid AA; James IM; Kaye CM; Lewellen OR; Roberts E; Sankey M; Smith J; Templeton R; Thomas RJ
    Biopharm Drug Dispos; 1981; 2(2):103-14. PubMed ID: 7248475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
    Sankey MG; Gulaid A; Kaye CM
    J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acebutolol pharmacokinetics in renal failure.
    Smith RS; Warren DJ; Renwick AG; George CF
    Br J Clin Pharmacol; 1983 Sep; 16(3):253-8. PubMed ID: 6626416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
    Zaman R; Jack DB; Wilkins MR; Kendall MJ
    Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the pharmacokinetics of acebutolol.
    Kaye CM; Kumana CR; Leighton M; Hamer J; Turner P
    Clin Pharmacol Ther; 1976 Apr; 19(4):416-20. PubMed ID: 1269192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
    Ohashi K; Warrington SJ; Kaye CM; Houghton GW; Dennis M; Templeton R; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):561-5. PubMed ID: 7295489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.
    Roux A; Le Liboux A; Delhotal B; Gaillot J; Flouvat B
    Eur J Clin Pharmacol; 1983; 24(6):801-6. PubMed ID: 6884417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS; Burm JP
    Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
    Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
    Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].
    Kukes VG; Gneushev ET; Mamedov TSh; Gneusheva IA
    Farmakol Toksikol; 1991; 54(1):53-5. PubMed ID: 1860501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
    Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
    J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent acebutolol disposition after oral administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1978 Nov; 24(5):542-7. PubMed ID: 699478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of acebutolol].
    Collins RF
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3223-8. PubMed ID: 768905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acebutolol and oral surgery: plasma levels following a single oral dose.
    Fergusson NV; Dalgleish JG; Saunders DA
    Ann R Coll Surg Engl; 1985 Mar; 67(2):124-6. PubMed ID: 3883878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol.
    Zaman R; Wilkins MR; Kendall MJ; Jack DB
    Biopharm Drug Dispos; 1984; 5(1):91-5. PubMed ID: 6704510
    [No Abstract]   [Full Text] [Related]  

  • 18. Acebutolol and coronary artery surgery. Plasma levels following oral pre-operative treatment.
    Thoms GM; Reece IJ; Odom NJ; Kaye CM; Sankey MG
    Anaesthesia; 1982 Nov; 37(11):1078-83. PubMed ID: 6982635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
    Munn S; Bailey RR; Begg E; Ebert R; Ferry DG
    N Z Med J; 1980 Apr; 91(658):289-91. PubMed ID: 6930006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
    Mostafavi SA; Foster RT
    Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.